Latest SYK reports update at 2024-02-14: 202320222021
Stryker Corporation logo

Stryker Corporation SYK

$ 335.61 -0.46%

Country

usaUSA

IPO year

-

Industry

Medical devices

Stock Exchange

NYSESPB

CEO

Mr. Kevin Lobo

Employees in the company

40 000

Shares

380 M

Market Cap[1]

$ 127 B

EBITDA (LTM)

$ 4.02 B

P/E (LTM)

36.88

P/S (LTM)

5.45

EPS (LTM)

7.49

Stryker Corporation is an international company specializing in the production of medical equipment and instruments for surgery. The company was founded in 1941 in the United States and has since become one of the leaders in its field.

Stryker Corporation offers a wide range of products, including implants for orthopedics, neurosurgery, traumatology, and other areas of medicine, as well as tools for surgical operations and rehabilitation equipment.

The company is actively developing and expanding its business around the world. Today, SYK has offices in more than 100 countries and holds leading positions in the medical equipment market.

One of the company's main goals is to create innovative products that will help improve the quality of life for patients and facilitate the work of medical professionals. Stryker Corporation also actively works on improving its technologies and processes to ensure high-quality products and maximum safety for patients.

Stryker Corporation is an example of a successful business that combines innovation, quality, and responsibility to patients.

Other stocks of industry "Medical devices"

Issuer Price % 24h Market Cap Exchange Country
Avinger Avinger
AVGR
$ 3.73 -5.08 % $ 2.93 M Nasdaq Capital Market usaUSA
Natus Medical Incorporated Natus Medical Incorporated
NTUS
$ 31.08 1.94 % $ 1.05 B Nasdaq Global Select Market,SPB usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
$ 4.1 -0.97 % $ 54.4 M Nasdaq Capital Market usaUSA
GBS GBS
GBS
$ 0.47 -0.57 % $ 7.12 M Nasdaq Global Market usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
$ 9.22 24.59 % $ 44.8 M Nasdaq Global Select Market chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
$ 3.05 -5.86 % $ 30.6 M Nasdaq Capital Market usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 28.34 -0.25 % $ 2.27 B Nasdaq Global Select Market,SPB usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 41.86 0.94 % $ 528 M Nasdaq Global Select Market usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
$ 20.0 0.15 % $ 844 M Nasdaq Global Select Market,SPB usaUSA
Neovasc Neovasc
NVCN
$ 30.03 - $ 111 M Nasdaq Capital Market canadaCanada
Apollo Endosurgery Apollo Endosurgery
APEN
$ 10.0 - $ 475 M Nasdaq Global Market usaUSA
Titan Medical Titan Medical
TMDI
$ 0.14 -26.32 % $ 19.6 M Nasdaq Global Select Market canadaCanada
BIOLASE BIOLASE
BIOL
$ 0.15 - $ 192 K Nasdaq Capital Market usaUSA
Sintx Technologies Sintx Technologies
SINT
$ 0.04 10.38 % $ 149 K Nasdaq Capital Market usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
$ 3.41 2.4 % $ 55.4 M Nasdaq Capital Market usaUSA
ShockWave Medical ShockWave Medical
SWAV
$ 330.0 0.31 % $ 12.1 B Nasdaq Global Select Market,SPB usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 1.45 -2.03 % $ 50.2 M Nasdaq Global Select Market usaUSA
TransMedics Group TransMedics Group
TMDX
$ 92.08 3.17 % $ 2.99 B Nasdaq Global Market usaUSA
Viemed Healthcare Viemed Healthcare
VMD
$ 8.31 3.75 % $ 319 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.